The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy

[1] Dinney CPN(2006)Therapy of invasive bladder cancer Urology 67 56-59

[2] Giuliani L(1985)Results of radical cystectomy for primary bladder cancer. retrospective study of more than 200 cases Urology 26 243-248

[3] Giberti C(1991)Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification J Urol 145 45-50

[4] Martorana G(2014)Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder Br J Cancer 111 444-451

[5] Pagano F(2018)Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy Eur Rev Med Pharmacol Sci 22 3027-3037

[6] Bassi P(2019)Prognostic significance of the lymphocyte-to-monocyte ratio in bladder cancer undergoing radical cystectomy: a meta-analysis of 5638 individuals Dis Markers 2019 7593560-360

[7] Galetti TP(2019)Comparison of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios in bladder cancer patients undergoing radical cystectomy BioMed Res Int 2019 3628384-269

[8] Hermanns T(2016)Elevated derived neutrophil-to-lymphocyte ratio corresponds with poor outcome in patients undergoing pre-operative chemotherapy in muscle-invasive bladder cancer Bladder Cancer 2 351-755

[9] Bhindi B(2017)Integrative assessment of pretreatment inflammation-, nutrition-, and muscle-based prognostic markers in patients with muscle-invasive bladder cancer undergoing radical cystectomy Oncology 93 259-357

[10] Wei Y(2015)Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma Korean J Urol 56 749-1085

[1] Dinney CPN(2006)Therapy of invasive bladder cancer Urology 67 56-59

[2] Giuliani L(1985)Results of radical cystectomy for primary bladder cancer. retrospective study of more than 200 cases Urology 26 243-248

[3] Giberti C(1991)Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification J Urol 145 45-50

[4] Martorana G(2014)Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder Br J Cancer 111 444-451

[5] Pagano F(2018)Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy Eur Rev Med Pharmacol Sci 22 3027-3037

[6] Bassi P(2019)Prognostic significance of the lymphocyte-to-monocyte ratio in bladder cancer undergoing radical cystectomy: a meta-analysis of 5638 individuals Dis Markers 2019 7593560-360

[7] Galetti TP(2019)Comparison of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios in bladder cancer patients undergoing radical cystectomy BioMed Res Int 2019 3628384-269

[8] Hermanns T(2016)Elevated derived neutrophil-to-lymphocyte ratio corresponds with poor outcome in patients undergoing pre-operative chemotherapy in muscle-invasive bladder cancer Bladder Cancer 2 351-755

[9] Bhindi B(2017)Integrative assessment of pretreatment inflammation-, nutrition-, and muscle-based prognostic markers in patients with muscle-invasive bladder cancer undergoing radical cystectomy Oncology 93 259-357

[10] Wei Y(2015)Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma Korean J Urol 56 749-1085